India’s regenerative medicine market continues to advance at a rapid pace fueled by rising healthcare demands as well as significant investments and rapid progress in biotechnological frontiers. A sector with an estimated compound annual growth rate (CAGR) of 20-30 percent and covering areas such as stem cell therapy, gene therapy and tissue engineering is changing the Indian healthcare story. Regenerative medicine holds great promise for the management and even cure of chronic diseases such as diabetes, cardiovascular problems and neurodegenerative disorders that are becoming increasingly common in India.

With a large population of patients, the country also has a genetically diverse population, which makes it an ideal environment for clinical research and trials. It has attracted both local as well as international investors who are keen to invest in the new treatment options available in India’s fast growing healthcare environment. In addition, government initiatives such as ‘Make in India’, are also enabling domestic biotech companies by offering incentives for companies to invest in R&D, innovate within its limits. Additionally, regenerative medicine is growing by virtue of academic institutions and research facilities across India collaborating with Indian scientists and foreign experts. It facilitates the development and clinical application of novel treatments in Indian hospitals, through a...